← ANALYST RATINGS · TIPRANKS
InfuSystem Holdings (INFU): analyst forecast and price target
Analyst consensus
Moderate Buy2 Buy0 Hold0 Sell
Ratings of 2 analysts in the last 3 months · top analysts only12-month forecast
Based on 2 price targets given in the last 3 months, the average target is $20.00, the highest $20.00, the lowest $20.00. The average is +49.3% from the last price of $13.40.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Ben Haynor★★★★★★★★★★#11216 · hits 35% · avg −2.8% | Lake Street | $17.50 | Buy | +30.6% | Reiterated | 25.09.26on TipRanks 09:30 | −0.4%next day +2.0% · 5 days +3.8% | ↗ |
| Matt Hewitt★★★★★★★★★★#3011 · hits 47% · avg +4.1% | Craig-Hallum | — | Buy | — | Reiterated | 24.09.26on TipRanks 09:10 | 0.0%next day −0.4% · 5 days +1.4% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $10.50 → $14.50+38.1% | Buy | +8.2% | Reiterated | 18.09.26on TipRanks 03:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $10.00 → $14.00+40.0% | Buy | +4.5% | Reiterated | 18.09.26on TipRanks 03:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $10.00 → $14.00+40.0% | Buy | +4.5% | Upgrade | 18.09.26on TipRanks 03:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $9.50 → $13.50+42.1% | Hold | +0.7% | Reiterated | 18.09.26on TipRanks 03:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $10.00 → $14.00+40.0% | Buy | +4.5% | Reiterated | 18.09.26on TipRanks 03:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $14.00 → $14.50+3.6% | Buy | +8.2% | Reiterated | 18.09.26on TipRanks 03:05 | — | |
| Anderson Schock★★★★★★★★★★#6225 · hits 53% · avg +2.9% | B. Riley Securities | $12.00 → $20.00+66.7% | Buy | +49.3% | Assigned | 05.08.26on TipRanks 08:55 | −1.2%next day −2.1% · 5 days +0.4% | ↗ |
| Kyle Bauser★★★★★★★★★★#12304 · hits 37% · avg −14.9% | Roth MKM | $14.00 → $15.00+7.1% | Buy | +11.9% | Reiterated | 25.02.26on TipRanks Feb 24 15:29 | +12.7%next day −1.3% · 5 days +7.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering InfuSystem Holdings
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $18.75 at a price of $12.89 (+45.5%); now: $18.75 at $13.40 (+39.9%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 2 | 1 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 10.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.13 (from $0.12 to $0.15). Last quarter: $0.15.
Sales
Next quarter’s sales estimate — $37M (from $37M to $38M). Last quarter: $37M.
Best top-analyst consensus in the sector · Healthcare
About InfuSystem Holdings
- CEO: Carrie A. Lachance
- Employees: 467
- 3851 West Hamlin Road, Rochester Hills, MI, 48309, US
- www.infusystem.com
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Data from the stock’s TipRanks forecast page, read 240 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗